Cerecor

FDA clears Cerecor’s FP01

Wednesday, April 11, 2012

Baltimore-based biopharmaceutical company Cerecor’s Investigational New Drug (IND) application for FP01 for the treatment of cough has cleared the 30 day deliberation period by the FDA. 

[Read More]